Funder: National Institutes of Health

Due Dates: February 16, 2025 (New) | March 16, 2025 (Renewal/Resubmission/Revision) | June 16, 2025 (New) | July 16, 2025 (Renewal/Resubmission/Revision) | October 16, 2025 (New) | November 16, 2025 (Renewal/Resubmission/Revision)

Funding Amounts: Up to $275,000 direct costs over 2 years; no more than $200,000 in any single year.

Summary: Supports exploratory mechanistic and epidemiologic research on how co-infections contribute to cancer development, to inform prevention and treatment of infection-related cancers.

Key Information: Clinical trials are not allowed; studies focused solely on HIV or a single pathogen are not eligible.